Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye - A phase I clinical study

被引:31
作者
Nagl, M [1 ]
Miller, B [1 ]
Daxecker, F [1 ]
Ulmer, H [1 ]
Gottardi, W [1 ]
机构
[1] Univ Innsbruck, Inst Hyg, A-6010 Innsbruck, Austria
关键词
D O I
10.1089/jop.1998.14.283
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
N-chlorotaurine (NCT), an essential weak oxidative N-chloro compound produced by stimulated human leukocytes, shows bactericidal, fungicidal, virucidal and vermicidal efficacy. A double-blind, randomized and placebo controlled study was done to evaluate the tolerance of the aqueous NCT solution by application to rabbit and human conjunctiva. In six rabbits treated with 1% and 3% NCT regimen for nine days no ocular and behaviour changes could be observed. In a pilot study with two volunteers, treatment with 2.8% NCT for five days caused a self-limited conjunctival injection of one subject, while 1% NCT was well tolerated. Subsequently, eight healthy volunteers participated in a phase I clinical study. One percent NCT was applied for five days and was well tolerated by all subjects except for minimal eye burning after the application. Because of these positive results, usage of the antimicrobial agent NCT in ophthalmology is suggested.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 17 条
[1]   TAURINE MODULATION OF HYPOCHLOROUS ACID-INDUCED LUNG EPITHELIAL-CELL INJURY IN-VITRO - ROLE OF ANION TRANSPORT [J].
CANTIN, AM ;
BILODEAU, G ;
MARTEL, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :606-614
[2]   INHIBITION OF COLLAGENASE ACTIVITY BY N-CHLOROTAURINE, A PRODUCT OF ACTIVATED NEUTROPHILS [J].
DAVIES, JMS ;
HORWITZ, DA ;
DAVIES, KJA .
ARTHRITIS AND RHEUMATISM, 1994, 37 (03) :424-427
[3]  
GOTTARDI W, 1993, Patent No. 4041703
[4]  
Gottardi W., 1996, HYG MED, V21, P597
[5]  
GRISHAM MB, 1984, J BIOL CHEM, V259, P404
[6]  
LAMPERT MB, 1983, BLOOD, V62, P645
[7]   Activity of N-chlorotaurine against herpes simplex- and adenoviruses [J].
Nagl, M ;
Larcher, C ;
Gottardi, W .
ANTIVIRAL RESEARCH, 1998, 38 (01) :25-30
[8]  
Nagl M., 1992, HYG MED, V17, P431
[9]  
PARK E, 1995, J IMMUNOL, V154, P4778
[10]  
RAND MC, 1976, STANDARD METHODS EXA, P316